Skip to main content

Table 1 Demographic characteristics, clinical characteristics and outcomes of 58 patients with palatal adenoid cystic carcinoma

From: Radical resection and reconstruction in patients with adenoid cystic carcinoma in the minor salivary glands of the palate

Parameter

No. Of cases (%)

Survival without disease (%)

Survival with recurrence (%)

Death (%)

P-value

Sex

    

0.683

 Male

28 (48.3)

19/28 (67.9)

4/28 (14.2)

5/28 (17.9)

 

 Female

30 (51.7)

22/30 (73.3)

5/30 (16.7)

3/30 (10.0)

 

Age (y)

    

0.665

  ≤  60 years

47 (81.0)

32/47 (68.1)

8/47 (17.0)

7/47 (14.9)

 

  > 60 years

11 (19.0)

9/11 (81.8)

1/11 (9.1)

1/11 (9.1)

 

Tumor size (cm)

    

0.109

  ≤ 2 cm

9 (15.5)

9/9 (100.0)

0/9 (00.0)

0/9 (0.0)

 

  > 2 cm

49 (84.5)

32/49 (65.3)

9/49 (18.4)

8/49 (16.3)

 

Histopathologic grade

    

0.0001

 Low grade (I + II)

(14 + 18) (55.2)

30/32 (90.6)

0/32 (0.00)

2/32 (6.3)

 

 High grade (III + transformed)

(23 + 3) (44.8)

11/26 (42.3)

9/26 (34.6)

6/26 (23.1)

 

Perineural invasion

    

0.281

 Absent

10 (17.2)

9/10 (90.0)

1/10 (10.0)

0/10 (0.0)

 

 Present

48 (82.8)

32/48 (66.6)

8/48 (16.7)

8/48 (16.7)

 

Bone invasion

    

0.250

 Absent

6 (10.3)

6/6 (100.0)

0/6 (00.0)

0/6 (100.0)

 

 Present

52 (89.7)

35/52 (67.3)

9/52 (17.3)

8/52 (15.4)

 

Lymph node metastasis

    

0.015

 Absent

55 (94.8)

41/55 (74.6)

7/55 (12.7)

7/55 (12.7)

 

 Present

3 (5.2)

0/3 (0.0)

2/3 (66.7)

1/3 (33.3)

 

TNM stage

    

0.0001

 Early (I + II)

(9 + 35) (75.9)

39/44 (88.7)

2/44 (4.5)

3 /44 (6.8)

 

 Advanced (III + IV)

(11 + 3) (24.1)

2/14 (14.3)

7/14 (50.0)

5/14 (35.7)

 

Treatment

    

0.004

 Radical excision

44 (75.9)

36/44 (81.8)

4/44 (9.1)

4/44 (9.1)

 

 Radical excision with radiotherapy

14 (24.1)

5/14 (35.7)

5/14 (35.7)

4/14 (28.6)

 

Surgical margin

    

0.081

 R0

56 (96.6)

41/56 (73.2)

8/56

7/56

 

 R1

2 (3.4)

0/2 (0.0)

(14.3) 1/2 (50.0)

(12.5) 1/2 (50.0)

 

Ki-67 expressiona

    

0.003

 Low

40 (76.9)

31/40 (77.5)

5/40 (12.5)

4/40 (10.0)

 

 High

12 (23.1)

3/12 (25.0)

4/12 (33.3)

5/12 (41.7)

 
  1. aDetermined in paraffin-embedded specimens obtained from 52 patients